Table 4.
Clinical features analysis
| N° (%) Subjects from | ||||||
| Symptomatology | Present Study (n: 72) | South Africaa (n: 269) | Souh Africab (n: 11) | Western Europe c (n: 103) | Finlandd | |
| Before 1980 (n: 34) | After 1980 (n: 20) | |||||
| Acute | 20 (28) | 51 (19) | 0 (0) | 20 (20) | 10 (29) | 3 (15) |
| Cutaneous | 25 (35) | 156 (58) | 10 (91) | 61 (59) | 14 (42) | 13 (65) |
| Both | 27 (37) | 62 (23) | 1 (9) | 22 (21) | 10 (29) | 4 (20) |
| Asymptomatic | 15 (29) | 31 (10) | 17 (61) | ---------- | 19 (36) | 30 (60) |
| Acute | 20 (28) | 51 (19) | 0 (0) | 20 (20) | 10 (29) | 3 (15) |
| Cutaneous | 25 (35) | 156 (58) | 10 (91) | 61 (59) | 14 (42) | 13 (65) |
| Both | 27 (37) | 62 (23) | 1 (9) | 22 (21) | 10 (29) | 4 (20) |
| Asymptomatic | 15 (29) | 31 (10) | 17 (61) | ---------- | 19 (36) | 30 (60) |
| Acute | 20 (28) | 51 (19) | 0 (0) | 20 (20) | 10 (29) | 3 (15) |
| Cutaneous | 25 (35) | 156 (58) | 10 (91) | 61 (59) | 14 (42) | 13 (65) |
| Both | 27 (37) | 62 (23) | 1 (9) | 22 (21) | 10 (29) | 4 (20) |
| Asymptomatic | 15 (29) | 31 (10) | 17 (61) | ---------- | 19 (36) | 30 (60) |
The total number of symptomatic subjects were considered
a: Eales et al (1980), b: Hift et al, 2004, c: Whatley et al, 1999, d: von und zu Fraunberg et al, 2000.